Abstracts tagged "education and race/ethnicity"

Abstract Number: 1375 • 2014 ACR/ARHP Annual Meeting
Educational Level and Not Ethnicity an Important Determinant of Disease Progression in Patients with Rheumatoid Arthritis
Sharon Dowell¹, Gail S. Kerr², Yusuf Yazici³, Christopher Swearingen⁴, Mercedes Quinones⁵, Luis R. Espinoza⁶, Edward L. Treadwell⁷, Theresa Lawrence-Ford⁸, Yvonne Sherrer⁹, Angelia Mosley-WIlliams¹⁰, Ignacio Garcia-Valladares¹¹, Rodolfo Perez Alamino¹², Chunqiao Luo¹³, Akgun Ince¹⁴, Adrian Godoy¹ and John Amatruda¹⁵, ¹Division of Rheumatology, Howard University, Washington, DC, ²Rheumatology, Washington DC VAMC, Georgetown and Howard University, Washington, DC, ³Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, ⁴Pediatrics and Biostatistics, University of Arkansas, Little Rock, AR, ⁵Division of Rheumatology, Howard University Hospital, Washington, DC, ⁶Medicine-Section of Rheum, LSU Medical Center, New Orleans, LA, ⁷Dept Medicine Div of Rheum, East Carolina University, Greenville, NC, ⁸North Georgia Rheumatology Group, PC, Lawrenceville, GA, ⁹Rheum/Immunology, Centre Rheum Immunol Arthritis, Fort Lauderdale, FL, ¹⁰Rheumatology, Detroit VAMC, Detroit, MI, ¹¹Immunology and Rheumatology, Hospital General de Occidente, Zapopan, Jal., Mexico, ¹²internal Medicine, LSUHSC, New Orleans, LA, ¹³University of Arkansas for Medical Sciences, Little Rock, AR, ¹⁴Arthitis Consultants Inc, St. Louis University, St. Louis, MO, ¹⁵Rheumatology, Howard University, Washington, DC
Background/Purpose: Formal educational level is often used as a surrogate for socioeconomic status and in patients with rheumatoid arthritis (RA), low levels have been associated…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].